Anti CD40LG pAb (ATL-HPA045827 w/enhanced validation)

Atlas Antibodies

SKU:
ATL-HPA045827-100
  • Immunohistochemical staining of human rectum shows strong cytoplasmic positivity in leukocytes.
  • Western blot analysis in control (vector only transfected HEK293T lysate) and cD40LG over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY400020).
Shipping:
Calculated at Checkout
$486.00
Adding to cart… The item has been added
Protein Description: CD40 ligand
Gene Name: CD40LG
Alternative Gene Name: CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000031132: 74%, ENSRNOG00000000871: 77%
Entrez Gene ID: 959
Uniprot ID: P29965
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Product Specifications
Application WB, IHC
Reactivity Human
Clonality Polyclonal
Host Rabbit
Immunogen LTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVS
Gene Sequence LTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVS
Gene ID - Mouse ENSMUSG00000031132
Gene ID - Rat ENSRNOG00000000871
Buffer 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.



Documents & Links for Anti CD40LG pAb (ATL-HPA045827 w/enhanced validation)
Datasheet Anti CD40LG pAb (ATL-HPA045827 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti CD40LG pAb (ATL-HPA045827 w/enhanced validation)



Citations for Anti CD40LG pAb (ATL-HPA045827 w/enhanced validation) – 1 Found
Pollack, Karlyn E; Meneveau, Max O; Melssen, Marit M; Lynch, Kevin T; Koeppel, Alexander F; Young, Samuel J; Turner, Stephen; Kumar, Pankaj; Sol-Church, Katia; Mauldin, Ileana S; Slingluff, Craig L Jr. Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment. Journal For Immunotherapy Of Cancer. 2020;8(1)  PubMed